The ECG Vertigo in Diabetes and Cardiac Autonomic Neuropathy

Article, Review English OPEN
Voulgari, Christina; Tentolouris, Nicholas; Stefanadis, Christodoulos;
(2011)
  • Publisher: Hindawi Publishing Corporation
  • Journal: Experimental Diabetes Research,volume 2,011 (issn: 1687-5214, eissn: 1687-5303)
  • Related identifiers: pmc: PMC3124253, doi: 10.1155/2011/687624
  • Subject: Review Article | Article Subject
    mesheuropmc: cardiovascular system

The importance of diabetes in the epidemiology of cardiovascular diseases cannot be overemphasized. About one third of acute myocardial infarction patients have diabetes, and its prevalence is steadily increasing. The decrease in cardiac mortality in people with diabete... View more
  • References (124)
    124 references, page 1 of 13

    Schnell, O., Otter, W., Standl, E.. The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice. Diabetes care. 2009; 32: S326-S330

    Van Dieren, S., Beulens, J. W. J., Van Der Schouw, Y. T., Grobbee, D. E., Neal, B.. The global burden of diabetes and its complications: an emerging pandemic. European Journal of Cardiovascular Prevention and Rehabilitation. 2010; 17: S3-S8

    Voulgari, C., Papadogiannis, D., Tentolouris, N.. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vascular Health and Risk Management. 2010; 6: 883-903

    Boudina, S., Abel, E. D.. Diabetic cardiomyopathy revisited. Circulation. 2007; 115 (25): 3213-3223

    Theosophy, null. Ancient landmarks: plato and aristotle. Theosophy. 1939; 27 (11): 483-491

    Zoungas, S., Patel, A.. Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies. Annals of the New York Academy of Sciences. 2010; 1212 (1): 29-40

    Miller, T. D., Redberg, R. F., Wackers, F. J. T.. Screening asymptomatic diabetic patients for coronary artery disease: why not?. Journal of the American College of Cardiology. 2006; 48 (4): 761-764

    Beller, G. A.. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?. Journal of the American College of Cardiology. 2007; 49 (19): 1918-1923

    Poirier, P., Després, J.-P., Bertrand, O. F.. Identifying which patients with diabetes should be tested for the presence of coronary artery disease—the importance of baseline electrocardiogram and exercise testing. Canadian Journal of Cardiology. 2006; 22: 9A-15A

    Aneja, A., Tang, W. H. W., Bansilal, S., Garcia, M. J., Farkouh, M. E.. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. American Journal of Medicine. 2008; 121 (9): 748-757

  • Metrics
    No metrics available
Share - Bookmark